FIELD: medicine.
SUBSTANCE: daily urine samples are analysed, rate of main metabolite of melatonin, 6-sulphatoxymelatonin is defined in it with the method of enzyme immunodetection, and at the value of the least of 28.97 ng/ml and above existence of respiration disturbance during sleep, including obstructive sleep apnea, is forecasted.
EFFECT: method enables to prognosticate the occurrence of respiration disturbance during sleep, including obstructive sleep apnea in children suffering from obesity.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SLEEP DISTURBANCES IN BOYS WITH OBESITY | 2012 |
|
RU2479841C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF OBSTRUCTIVE SLEEP APNOEA SYNDROME IN ADOLESCENT BOYS SUFFERING OBESITY | 2020 |
|
RU2739689C1 |
| METHOD FOR DETERMINATION OF INDICATIONS FOR POLYSOMNOGRAPHY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2009 |
|
RU2412644C1 |
| METHOD OF DETERMINING INDICATIONS FOR POLYSOMNOGRAPHIC EXAMINATION OF PATIENTS WITH ARTERIAL HYPERTENSION | 2007 |
|
RU2372025C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF SEVERE OBSTRUCTIVE SLEEP APNEA SYNDROME | 2008 |
|
RU2394485C1 |
| METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| METHOD FOR DIAGNOSING AND CORRECTING RESPIRATORY DISORDERS IN SLEEPING | 2000 |
|
RU2197893C2 |
| METHOD FOR DETERMINING RESPIRATORY, CARDIOVASCULAR AND METABOLIC DISORDERS RISK DEGREE IN PATIENTS SUFFERING FROM DESTRUCTIVE RESPIRATION DISORDERS IN SLEEPING | 2005 |
|
RU2308886C2 |
| METHOD OF TREATING METABOLIC SYNDROM | 2010 |
|
RU2452523C1 |
